Literature DB >> 21288929

Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.

Eduardo Ramacciotti1, Melanie Clark, Nasir Sadeghi, Debra Hoppensteadt, Indermohan Thethi, Marise Gomes, Jawed Fareed.   

Abstract

BACKGROUND: The contaminant isolated from contaminated heparin was oversulfated chondroitin sulfate (OSCS). Other possible contaminants should be evaluated.
METHODS: Contaminants were isolated from recalled contaminated heparin and were compared to OSCS from animal sources and to heparin by-products synthetically persulfated.
RESULTS: A great variability in molecular weight was observed in the isolated contaminants. Dermatan sulfate with high-molecular-weight in addition to OSCS was detected. Oversulfated chondroitin sulfate from different sources as well as heparin by-products produced activation of prekallikrein to kallikrein at variable rates as measured by the generation of kallikrein. All agents produced activation of the complement system. All compounds formed complexes with platelet factor 4 (PF4) and all produced (14)C serotonin release in the heparin-induced thrombocytopenia (HIT) analysis. The agents also exhibited variable anticoagulant responses that were mostly mediated via heparin cofactor II.
CONCLUSION: These results suggest that heparin contaminants represent a heterogeneous group of oversulfated glycosaminoglycans (OSGAGs) which may mediate multiple pathophysiologic responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288929     DOI: 10.1177/1076029610392214

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  5 in total

Review 1.  Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary.

Authors:  Jacobus R B J Brouwers; Jeanine E Roeters van Lennep; Maarten J Beinema
Journal:  Br J Clin Pharmacol       Date:  2019-09-04       Impact factor: 4.335

Review 2.  Tools for the Quality Control of Pharmaceutical Heparin.

Authors:  Anthony Devlin; Courtney Mycroft-West; Patricia Procter; Lynsay Cooper; Scott Guimond; Marcelo Lima; Edwin Yates; Mark Skidmore
Journal:  Medicina (Kaunas)       Date:  2019-09-25       Impact factor: 2.430

Review 3.  New methods to study the composition and structure of the extracellular matrix in natural and bioengineered tissues.

Authors:  Jürgen Schiller; Daniel Huster
Journal:  Biomatter       Date:  2012 Jul-Sep

Review 4.  Heparin Mimetics: Their Therapeutic Potential.

Authors:  Shifaza Mohamed; Deirdre R Coombe
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-02

5.  Pentosan Polysulfate Inhibits Attachment and Infection by SARS-CoV-2 In Vitro: Insights into Structural Requirements for Binding.

Authors:  Sabrina Bertini; Anna Alekseeva; Stefano Elli; Isabel Pagani; Serena Zanzoni; Giorgio Eisele; Ravi Krishnan; Klaus P Maag; Christian Reiter; Dominik Lenhart; Rudolf Gruber; Edwin A Yates; Elisa Vicenzi; Annamaria Naggi; Antonella Bisio; Marco Guerrini
Journal:  Thromb Haemost       Date:  2022-03-23       Impact factor: 6.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.